Shifting the lines against central nervous system disorders

« A disruptive technology, which can be applied in the treatment of numerous conditions »

> Press releases

THERANEXUS raises approximately 2.2 million euros in a placement reserved to a category of persons 

Dowload PDF File (615 Ko)

THERANEXUS announces the launch of a capital increase by private placement for a maximum amount of euro 4 million

Download PDF File (284 Ko)

THERANEXUS reports cash position as of June 30th 2019

Download PDF File (268 Ko)

Theranexus and Beyond Batten Disease Foundation (BBDF) announce agreement in
principle to develop and market Batten disease drug candidate BBDF 101

Download PDF File (416 Ko)

THERANEXUS invited to join in the HealthTech Investor Days (HTDI) 24 & 25 June in Paris

Download PDF File (363 Ko)

THERANEXUS announces the formation of its scientific Board

Download PDF File (375 Ko)

THERANEXUS to present new data on neuron-glia interactions at two scientific events

Download PDF File (380 Ko)

THERANEXUS announces issuance of Chinese patent covering its drug candidate THN102

Download PDF File (381 Ko)

THERANEXUS provides 2018 full-year results and update on activities

Download PDF File (416 Ko)

THERANEXUS announces research collaboration with IRISA using artificial intelligence technologies to enhance therapeutic targeting of neuroglial interactions

Download PDF File (376 Ko)